Related references
Note: Only part of the references are listed.Effect of rheumatoid arthritis and age on metacarpal bone shaft geometry and density: A longitudinal pQCT study in postmenopausal women
D. Aeberli et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis
Jing-jing Tong et al.
CLINICAL RHEUMATOLOGY (2020)
HR-pQCT Measures of Bone Microarchitecture Predict Fracture: Systematic Review and Meta-Analysis
Nicholas Mikolajewicz et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
Dolores Shoback et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE EXECUTIVE SUMMARY
Pauline M. Camacho et al.
ENDOCRINE PRACTICE (2020)
Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017
Lisa Lindner et al.
RHEUMATOLOGY INTERNATIONAL (2020)
Association between grip strength and bone mineral density in general US population of NHANES 2013-2014
Yingying Luo et al.
ARCHIVES OF OSTEOPOROSIS (2020)
Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis
Y. Wang et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study
A. Shin et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Sex differences in frailty and its association with low bone mineral density in rheumatoid arthritis
Katherine D. Wysham et al.
BONE REPORTS (2020)
Rheumatoid arthritis in tight disease control is no longer risk of bone mineral density loss
Ichiro Yoshii et al.
OSTEOPOROSIS AND SARCOPENIA (2020)
Evaluation of Risk Factors for Falls in Patients with Rheumatoid Arthritis
Marcin Mikos et al.
MEDICAL SCIENCE MONITOR (2020)
Incidence and Risk of Glucocorticoid-Associated Adverse Effects in Patients With Rheumatoid Arthritis
Jessica C. Wilson et al.
ARTHRITIS CARE & RESEARCH (2019)
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
Richard Eastell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial
Tsutomu Takeuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Medications associated with fracture risk in patients with rheumatoid arthritis
Gulsen Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis
Giovanni Orsolini et al.
PHARMACOLOGICAL RESEARCH (2019)
Frailty and risk of osteoporotic fractures in patients with rheumatoid arthritis: Data from the Ontario Best Practices Research Initiative
Guowei Li et al.
BONE (2019)
Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis
T. Tomizawa et al.
ARTHRITIS RESEARCH & THERAPY (2019)
In which patients does lumbar spine trabecular bone score (TBS) have the largest effect?
P. Martineau et al.
BONE (2018)
The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials
Anne-Birgitte Garm Blavnsfeldt et al.
BONE (2018)
Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis
S. Jin et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Association of High Anti-Cyclic Citrullinated Peptide Seropositivity and Lean Mass Index With Low Bone Mineral Density in Rheumatoid Arthritis
Katherine D. Wysham et al.
ARTHRITIS CARE & RESEARCH (2018)
The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis
Ratanapha Phuan-udom et al.
CLINICAL RHEUMATOLOGY (2018)
Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients
Cristina Regueiro et al.
PLOS ONE (2018)
Glucocorticoid-Induced Osteoporosis
Lenore Buckley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Glucocorticoid Excess in Bone and Muscle
Amy Y. Sato et al.
CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM (2018)
Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX® : a registry study of RA with osteoporosis/fracture
Tien-Tsai Cheng et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study
Ramon Mazzucchelli et al.
RMD OPEN (2018)
Bone mineral density of postmenopausal women with rheumatoid arthritis depends on disease duration regardless of treatment
Yu Mori et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2017)
Muscle Deficits in Rheumatoid Arthritis Contribute to Inferior Cortical Bone Structure and Trabecular Bone Mineral Density
Joshua F. Baker et al.
JOURNAL OF RHEUMATOLOGY (2017)
Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients
Irene Llorente et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Variations in Radiographic Procedure Use for Medicare Patients With Rheumatoid Arthritis
Gabriela Schmajuk et al.
ARTHRITIS CARE & RESEARCH (2017)
Effects of Teriparatide on Joint Erosions in Rheumatoid Arthritis A Randomized Controlled Trial
D. H. Solomon et al.
ARTHRITIS & RHEUMATOLOGY (2017)
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Lenore Buckley et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients
Giovanni Orsolini et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study
Dam Kim et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis
Serena Bugatti et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Rheumatoid arthritis patients with hip fracture: a nationwide study
Y. -C. Lin et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies
Arnd Kleyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Relationship of Weight, Height, and Body Mass Index With Fracture Risk at Different Sites in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women (GLOW)
Juliet E. Compston et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Clinician's Guide to Prevention and Treatment of Osteoporosis
F. Cosman et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis
Barbara Hauser et al.
RHEUMATOLOGY (2014)
The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis
Kensuke Kume et al.
RHEUMATOLOGY (2014)
Associations between body composition and bone density and structure in men and women across the adult age spectrum
Joshua F. Baker et al.
BONE (2013)
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
Ulrike Harre et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Effects of Teriparatide Versus Alendronate for Treating Glucocorticoid-Induced Osteoporosis Thirty-Six-Month Results of a Randomized, Double-Blind, Controlled Trial
Kenneth G. Saag et al.
ARTHRITIS AND RHEUMATISM (2009)
Bone mineral density in the hand as a predictor for mortality in patients with rheumatoid arthritis
Christina Book et al.
RHEUMATOLOGY (2009)
FRAX™ and the assessment of fracture probability in men and women from the UK
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis
C. Book et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2008)
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis
T. P. van Staa et al.
ARTHRITIS AND RHEUMATISM (2006)
Inflammatory markers and loss of muscle mass (sarcopenia) and strength
Laura A. Schaap et al.
AMERICAN JOURNAL OF MEDICINE (2006)
High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass
K Natsui et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-α antibody:: a prospective open-label pilot study
U Lange et al.
RHEUMATOLOGY (2005)
IL-1 mediates TNF-induced osteoclastogenesis
S Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density
MC Lodder et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women:: The health ABC study
M Visser et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2002)
Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis
K Shibuya et al.
CLINICAL RHEUMATOLOGY (2002)
Share Paper
